Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1297
Peer-review started: September 12, 2022
First decision: October 3, 2022
Revised: September 22, 2022
Accepted: October 27, 2022
Article in press: October 27, 2022
Published online: November 27, 2022
Processing time: 73 Days and 10.6 Hours
Colorectal anastomotic leakage (CAL) is a surgical complication with a huge impact on morbidity and mortality. Early diagnosis of CAL can reduce these complications as well as hospital readmission and overall healthcare costs.
Decision models have been developed to increase the diagnostic accuracy of CAL. A user-friendly score applied in routine clinical practice can have a positive impact on the timely diagnosis of CAL and minimize healthcare costs.
To develop a score capable of assisting clinicians in early and accurate detection of CAL. In addition, we aimed to assess the cost-effectiveness of using this classification system in daily clinical practice.
From March 1, 2017 to August 31, 2019, 396 patients who underwent colorectal resection with anastomosis were enrolled in a prospective, observational, single center study. A score based on the least absolute shrinkage and selection operator method developed and named the Early ColoRectAL Leakage (E-CRALL) score. The score performance and CAL threshold from postoperative day (POD) 3 to POD5 were estimated. A cost-minimization analysis was also conducted.
This study included 396 patients who underwent colorectal resection with anastomosis. Among them, 6.3% (n = 25) developed CAL. The median time to CAL diagnosis was 9.0 ± 6.8 d. From POD3 to POD5, the area under the receiver operating characteristic curve of the E-CRALL score was 0.82, 0.84, and 0.95, respectively. The score anticipated CAL diagnosis in an average of 5.2 d and 4.1 d if used on POD3 and POD5, respectively. Overall costs in patients who developed CAL were markedly higher in comparison with patients who did not develop CAL. The E-CRALL warning score was associated with a cost savings of €421442.20.
The E-CRALL score demonstrated a high predictive ability, with sensitivity and a negative predictive value of 100% on POD4 and a significant specificity (86.6%) on POD5. The routine adoption of the E-CRALL score may help prioritize CAL detection. Overall costs decreased after E-CRALL use, revealing a noteworthy reduction of in-hospital costs, independent of CAL status, which was primarily from the reduction in the LOHS for patients who did not develop CAL.
A prospective, multicentric study will be conducted to test the warning score and promote external validation of our research.